Schedule 13G ownership disclosure
Emergent BioSolutions Inc
Security class unavailable · CUSIP: 29089Q105
Event date: 2014-05-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-14-003506
- Form type
- SC 13G
- Filer
- Broadfin Capital, LLC
- CIK
- CIK 1511901
- Filed
- May 19, 2014
- Reporting period
- May 09, 2014
- Description
- Schedule 13G beneficial ownership